Send the following on WhatsApp
Continue to ChatEfficacy and Safety of Recombinant Human Prourokinase in the Treatment of Acute Ischemic Stroke Within 4.5 Hours of Stroke Onset A Phase 3 Randomized Clinical Trial https://emergencymed.org.il/efficacy-and-safety-of-recombinant-human-prourokinase-in-the-treatment-of-acute-ischemic-stroke-within-4-5-hours-of-stroke-onset-a-phase-3-randomized-clinical-trial/